# Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer

> **NCT00842244** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 22 (actual)

## Conditions studied

- Stomach Neoplasms
- Advanced Gastric Cancer

## Interventions

- **DRUG:** axitinib
- **DRUG:** capecitabine
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT00842244
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-12
- **Final completion:** 2012-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842244, "Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00842244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*